Showing 1 - 6 results of 6 for search 'Shinsuke Iida', query time: 0.02s Refine Results
  1. 1
    Prevalence of CCR7‐Positive CD8 T Cells as a Prognostic Factor in B‐Cell Maturation Antigen ‐Targeted Chimeric Antigen Receptor T Cell Therapy

    Prevalence of CCR7‐Positive CD8 T Cells as a Prognostic Factor in B‐Cell Maturation Antigen ‐Targeted Chimeric Antigen Receptor T Cell Therapy by Yoshiaki Marumo, Masaki Ri, Toru Ebina, Tomoyuki Nakamura, Yoshiko Oshima, Takahiro Nakashima, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Takaomi Sanda, Hirokazu Komatsu, Shinsuke Iida

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Characteristics and treatment patterns in patients with multiple myeloma in Japan: A retrospective cohort analysis.

    Characteristics and treatment patterns in patients with multiple myeloma in Japan: A retrospective cohort analysis. by Shinsuke Iida, Yusuke Yasutomi, Yevgeniy Samyshkin, Yi-Chen Chen, Chi-Chang Chen, Wen Shi Lee, Seok-Won Kim, Catherine McGuiness, Zifan Zhou, Simon McNamara

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors

    JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors by Yang Li, Taeko Hayakawa, Shinsuke Iida, Toshiaki Yoshikawa, Yusuke Ito, Satoshi Inoue, Yuichi Ishikawa, Takahiro Nakashima, Tetsuya Matsukawa, Hitoshi Kiyoi, Yuki Kagoya, Hitomi Kasuya, Haosong Zhang, Tsunenori Ouchida

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone

    Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone by Takuto Tachita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors

    Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors by Takashi Kojima, Kazuhiro Kakimi, Takuro Saito, Shinsuke Iida, Hisashi Wada, Hiroyoshi Nishikawa, Jun Nakajima, Susumu Suzuki, Koichi Jinushi, Koji Kurose, Taishi Takahara, Tomoki Makino, Tetsuya Ogawa, Yuichiro Doki, Mikio Oka, Ryuzo Ueda

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

    Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review by Francesca Gay, Francesca Gay, Elena Zamagni, Elena Zamagni, Craig Emmitt Cole, Craig Emmitt Cole, Christof Scheid, Malin Hultcrantz, Justyna Chorazy, Ike Iheanacho, Anuja Pandey, Jacopo Bitetti, Natalie Boytsov, Molly Purser, Simon McNamara, Shinsuke Iida

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: